ARTV Artiva Biotherapeutics, Inc.
What the filings say Pressure ▼
The company can sell stock into the market any day at prevailing prices — steady supply.
Radar 56 (elevated attention) · dilution pressure elevated · listing risk low · governance risk low · runway 50.0 mo · strongest signal: Shelf filed (Aug 6, 2026)
Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.
56 Radar · attention score (0–100)
67 Dilution pressure · financing + balance sheet
27 Listing risk · exchange standards
0 Governance risk · reporting, auditor, going concern
Analyst note No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.
Pro on ARTV Alerts One email the morning ARTV files anything that matches your rules (types, minimum score, setups).
12-month history Every signal and setup for ARTV back a year, not just 30 days — see how the current setup built.
Full analyst notes What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV All 985 flagged companies, same-day, sortable and exportable.
Balance sheet (XBRL) $301.5M cash + short-term investments as of Jun 30, 2026
50.0 mo estimated runway (4x latest quarterly operating cash burn)
$347.5M stockholders' equity as of Jun 30, 2026
$15.0M public float (10-K cover)
48.9M shares outstanding as of Jul 31, 2026 · was 24.7M Apr 30, 2026
Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 47 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.
Signal timeline Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.
Date Signal Evidence Score Aug 6, 2026 ▼ Shelf filed S-3 filed 2026-08-06 filing
39 Aug 6, 2026 ▼ ATM program “atm” language in S-3 (S-3) filed 2026-08-06 filing
34 Aug 3, 2026 ▼ Reverse split “reverse split” language in DEF 14A (DEF 14A) filed 2026-08-03 filing
27 Jul 31, 2026 · Form 4 burst 5 Form 4 filings in 30 days filing
15 Jul 23, 2026 · 13D amendment Schedule 13D/A filed 2026-07-23 filing
24 Jun 30, 2026 ▼ Share count +25% Shares outstanding 24,716,672 (2026-04-30) -> 48,890,121 (2026-07-31), +98% filing
38
Quiet Alpha Automated SEC-filing intelligence for US microcaps. Updated every weekday morning from SEC EDGAR · last run 2026-08-16.
Newsletter ·
X ·
[email protected] Quiet Alpha is an automated financial research publication. It is not investment advice, not a recommendation to buy or sell any security, and not personalized to any reader. Data are derived from public SEC filings and may contain errors; verify against the source documents linked in each item. Quiet Alpha accepts no compensation from issuers. Microcap securities are illiquid and can lose most or all of their value.